Evidence map›Paper›PMID 15122590›Full record

ArticleInternational journal of cancer2004

Gene expression analysis in Interleukin-12-induced suppression of mouse mammary carcinoma.

Xiaoyan Shi, Jianguo Liu, Zhaoying Xiang, Maki Mitsuhashi, Rita S Wu, Xiaojing Ma

Abstract read
In one paragraph

Article in International journal of cancer, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. New insights into IL-12-mediated tumor suppression.Cell death and differentiation · 2015
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Chronic stress and susceptibility to skin cancer.Journal of the National Cancer Institute · 2005
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaoyan ShiDepartment of Microbiology and Immunology, Weill Medical College of Cornell University, New York, N Y10021, USA.
Jianguo Liu
Zhaoying Xiang
Maki Mitsuhashi
Rita S Wu
Xiaojing Ma

Funding

Regulation of IL-12 Expression and Activity by OncogenesR01CA100223 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MA, XIAOJING · 2004 to 2008
$1.5M
NCI NIH HHS R01 CA100223
6 · The paper itself

Abstract

Interleukin-12 (IL-12) has potent antitumor activities via natural killer cells and cytotoxic T lymphocytes. However, the molecular mechanisms whereby IL-12 induces tumoricidal activities are poorly understood. Here, we report the genome-wide analysis of gene expression in a primary murine mammary carcinoma model that resembles human breast cancer, following the therapeutic application of recombinant IL-12, which restricted tumor growth and metastasis. IL-12 was able to curtail neovascularization in the tumor as well as enhance the number of tumor-infiltrating lymphocytes. Comprehensive examination of global gene expression revealed IL-12-induced molecular changes associated with tumor regression and reduced lung metastasis, thus providing a high-resolution snapshot of a host response against a developing malignancy and a rich source of potential targets for therapeutic intervention of breast cancer.

Indexed as

AnimalsFemaleGene Expression ProfilingInterleukin-12Lymphocytes, Tumor-InfiltratingMammary Neoplasms, ExperimentalMiceMice, Inbred BALB CNeovascularization, PathologicReverse Transcriptase Polymerase Chain ReactionInterleukin-12

Identifiers

PMID15122590
PMCPMC2957898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.